METASTATIC BREAST CANCER TREATMENT PATTERNS AND COSTS OF OUTPATIENT CARE UNDER THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM PERSPECTIVE

被引：0
|
作者：
Teich, V [1 ]
Teich, N. [1 ]
Nita, M. [2 ]
Donato, B. M. [3 ]
Rached, R. [2 ]
Rahal, E. [2 ]
机构：
[1] MedInsight, Rio De Janeiro, Brazil
[2] Bristol Myers Squibb SA, Sao Paulo, Brazil
[3] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75334-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A493 / A494
页数：2
相关论文
共 50 条
  • [31] Costs for Breast Cancer Care in the Military Health System: An Analysis by Benefit Type and Care Source
    Eaglehouse, Yvonne L.
    Manjelievskaia, Janna
    Shao, Stephanie
    Brown, Derek
    Hofmann, Keith
    Richard, Patrick
    Shriver, Craig D.
    Zhu, Kangmin
    MILITARY MEDICINE, 2018, 183 (11-12) : E500 - E508
  • [32] Characterization of health care resource utilization and costs in women with metastatic breast cancer in Medicaid
    Wang, Zhixiao
    Li, Xuan
    Faria, Claudio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [33] Impact of brain metastases on health care costs in metastatic breast cancer: A multinational study
    Walker, M. D.
    Lykopoulos, K.
    McLeod, E.
    Cottrell, S.
    Christova, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [34] STUDY OF THE TREATMENT PATTERNS IN METASTATIC BREAST CANCER PATIENTS IN A TERTIARY CARE HOSPITAL
    Sandeep, A.
    Singh, K.
    Sreedharan, N.
    Thunga, G.
    Kunhikatta, V
    VALUE IN HEALTH, 2013, 16 (03) : A155 - A155
  • [35] Treatment Sequencing Patterns and Associated Direct Medical Costs of Metastatic Breast Cancer Care in the United States, 2011 to 2021
    Chehayeb, Rachel Jaber
    Hood, Annette
    Wang, Xiaoliang
    Miksad, Rebecca
    Mougalian, Sarah Schellhorn
    Lustberg, Maryam B.
    Wang, Shi-Yi
    Greenup, Rachel A.
    Pusztai, Lajos
    Kunst, Natalia
    JAMA NETWORK OPEN, 2022, 5 (11) : e2244204
  • [36] Costs and Quality of Care of Type 2 Diabetes Patients Treatment in the Brazilian Public and Private Health Systems
    Bahia, Lucianaahia R.
    Araujo, Denizar V.
    Schaan, Beatriz D.
    Barufaldi, Laura
    Abreu, Gabriela
    Franco, Laercio J.
    DIABETES, 2013, 62 : A678 - A678
  • [37] THE COST OF STRONG OPIOID TREATMENT OF ONCOLOGICAL PAIN IN THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM
    Paloni, E. D. M. P.
    Bonachela Alves, F.
    Morais, A. D.
    Pereira, M. L.
    Bahmdouni, L.
    VALUE IN HEALTH, 2011, 14 (07) : A444 - A444
  • [38] THE COST OF A SCHIZOPHRENIA RELAPSE IN THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM
    Bahmdouni, L. S. K.
    Pereira, M. L.
    Ferreira, C. N.
    Santana, C. F. S. D.
    Salles, G. R. D.
    VALUE IN HEALTH, 2012, 15 (04) : A87 - A87
  • [39] COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE VERSUS OLANZAPINE, QUETIAPINE AND ZIPRAZIDONE FOR THE TREATMENT OF PATIENTS WITH SCHIZOPHRENIA UNDER THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM PERSPECTIVE
    Nishikawa, A. M.
    Clark, O. A. C.
    Pititto, L.
    VALUE IN HEALTH, 2014, 17 (03) : A217 - A217
  • [40] Breast Cancer Screening and Health Care Costs Reply
    Kunst, Natalia
    Gross, Cary P.
    JAMA INTERNAL MEDICINE, 2020, 180 (11) : 1553 - 1554
12345